|
CV Information
 PROFESOR MADYA DR. MOHD ZULFAKAR BIN MAZLAN
| |
|---|---|
|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
| 1 | EXTERNAL AGENCY (INTERNATIONAL), "A CLINICALLY-ORIENTED ANTIMICROBIAL RESISTANCE SURVEILLANCE NETWORK FOR HEALTHCARE-ASSOCIATED INFECTIONS (ACORN-HAI)" (01.10.2022 - 31.12.2024) (Principal) [ NATIONAL UNIVERSITY OF SINGAPORE (NUS) ] - Source: eR&I |
| 2 | EXTERNAL AGENCY (INTERNATIONAL), "EVALUATION OF AGREEMENT BETWEEN POINT-OF-CARE AND LABORATORY AUTOMATED IMMUNOASSAY IN PROCALCITONIN AND C REACTIVE PROTEIN MEASUREMENT AMONG CRITICALLY ILL PATIENTS" (01.06.2022 - 31.05.2023) (Principal) [ GUANGZHOU WONDFO BIOTECH CO., LTD. ] - Source: eR&I |
| 3 | EXTERNAL AGENCY (INTERNATIONAL), "CRITICAL CARE ASIA NETWORK (CCA) REGISTRY" (14.08.2021 - 13.08.2023) (Principal) [ MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT (MORU), THAILAND ] - Source: eR&I |
| 4 | EXTERNAL AGENCY (INTERNATIONAL), "MULTIPLE PARALLEL MULTI-CENTRE, RANDOMISED, SINGLE BLINDED CLINICAL TRIALS COMPARING CONSERVATIVE VS. LIBERAL OXYGENATION TARGETS IN MECHANICALLY VENTILATED ADULTS IN THE INTENSIVE CARE UNIT" (01.06.2021 - 31.05.2030) (Principal) [ MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND (MRINZ) ] - Source: eR&I |
| 5 | EXTERNAL AGENCY (INTERNATIONAL), "PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF CONTINUOUS BETALACTAM ANTIBIOTIC INFUSION COMPARED TO INTERMITTENT BETA-LACTAM ANTIBIOTIC INFUSION IN CRITICALLY ILL PATIENTS: A SUBSTUDY OF THE BLING III" (31.10.2019 - 31.10.2023) (Principal) [ THE GEORGE INSTITUTE FOR GLOBAL HEALTH, AUSTRALIA ] - Source: eR&I |
| 6 | , "ENTITLED "PREVALENCE, CAUSES , MANAGEMENT, AND OUTCOMES OF SEPSIS IN ASIA'S INTENSIVE CARE UNITS"" (09.01.2019 - 07.01.2020) [ National University Singapore ] - Source: HCMSv3 |
| 7 | , "“INTERNATIONAL OBSERVATIONAL STUDY TO UNDERSTAND THE IMPACT AND BEST PRACTICES OF AIRWAY MANAGEMENT IN CRITICALLY ILL PATIENTS (INTUBE)�" (01.01.2019 - 31.12.2019) [ UNIVERSITY HOSPITAL SAN GERARDO, with an address at Via Pergolesi 33, 20900 Monza Italy ] - Source: HCMSv3 |
| 8 | , "AN INTERNATIONAL, MULTI-CENTRE PROSPECTIVE PHARMACOKINETIC EVALUATION OF ANTIFUNGAL DRUG EXPOSURE IN INTENSIVE CARE UNIT PATIENTS RECEIVING CONVENTIONAL DOSING REGIMENS (SAFE-ICU) STUDY," (01.06.2016 - 31.12.2019) [ Unversity Queensland ] - Source: HCMSv3 |